RASILEZ HCT

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong SAR China, Lithuania, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug RASILEZ HCT contains a combination of these active pharmaceutical ingredients (APIs):

1	Aliskiren UNII 502FWN4Q32 - ALISKIREN
	Aliskiren is an orally active, non-peptide, potent and selective direct inhibitor of human renin. By inhibiting the enzyme renin, aliskiren inhibits the RAAS at the point of activation, blocking the conversion of angiotensinogen to angiotensin I and decreasing levels of angiotensin I and angiotensin II.
	Read more about Aliskiren
2	Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
	Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted.
	Read more about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RASILEZ HCT Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09XA52	Aliskiren and hydrochlorothiazide	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09X Other agents acting on the renin-angiotensin system → C09XA Renin-inhibitors
Discover more medicines within C09XA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1398764, 1398775, 1398786, 1398797, 1398809, 1398810, 1398821, 1398832, 1398843, 1398854, 1398865, 1398876, 1398887, 1398898, 1398900, 1398911, 1398922, 1398933, 1398944, 1398955, 1398966, 1398977, 1398988, 1398999, 1399002, 1399013, 1399024, 1399035, 1399046, 1399057, 1399068, 1399079, 1399080, 1399091, 1399103, 1399114
ES	Centro de información online de medicamentos de la AEMPS	08491012, 08491032, 08491052, 08491072
HK	Department of Health Drug Office	59014, 59015, 59016, 59017
LT	Valstybinė vaistų kontrolės tarnyba	1036029, 1036030, 1036031, 1036032, 1036033, 1036034, 1036035, 1036036, 1036037, 1036038, 1036039, 1036040, 1036041, 1036042, 1036043, 1036044, 1036045, 1036046, 1036047, 1036048, 1036049, 1036050, 1036051, 1036052, 1036053, 1036054, 1036055, 1036056, 1036057, 1036058, 1036059, 1036060, 1036061, 1036062, 1036063, 1036064, 1036065, 1036066, 1036067, 1036068, 1036080, 1036081, 1036082, 1036083, 1036084, 1036085, 1036086, 1036087, 1036088, 1036089, 1036090, 1036091, 1036092, 1036093, 1036094, 1036095, 1036096, 1036097, 1036098, 1036099, 1036100, 1036101, 1036102, 1036103, 1036104, 1036105, 1036106, 1036107, 1036108, 1036109, 1036110, 1036111, 1036112, 1036113, 1036114, 1036115, 1036116, 1036117, 1036118, 1036119
NL	Z-Index G-Standaard, PRK	89079, 89087, 89095, 89109
PL	Rejestru Produktów Leczniczych	100187024, 100204060, 100204082, 100204099
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53886001, W53886002, W53886003, W53886004, W53886005, W53886006, W53886007, W53886008, W53886009, W53886010, W53886011, W53886012, W53886013, W53886014, W53886015, W53886016, W53886017, W53886018, W53886019, W53886020, W53887001, W53887002, W53887003, W53887004, W53887005, W53887006, W53887007, W53887008, W53887009, W53887010, W53887011, W53887012, W53887013, W53887014, W53887015, W53887016, W53887017, W53887018, W53887019, W53887020, W53888001, W53888002, W53888003, W53888004, W53888005, W53888006, W53888007, W53888008, W53888009, W53888010, W53888011, W53888012, W53888013, W53888014, W53888015, W53888016, W53888017, W53888018, W53888019, W53888020, W53889001, W53889002, W53889003, W53889004, W53889005, W53889006, W53889007, W53889008, W53889009, W53889010, W53889011, W53889012, W53889013, W53889014, W53889015, W53889016, W53889017, W53889018, W53889019, W53889020